A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer.

Authors :: Mol, L.
Koopman, M.
Ottevanger, P. B.
Punt, C. J. A.
Source :: Annals of Oncology. Feb2010, Vol. 21 Issue 2, p415-418. 4p. 2 Charts.
Publication Year :: 2010
Abstract: Background: Early and correct assessment of treatment-related mortality is highly important in clinical cancer trials. However, no data are available on the quality of safety monitoring. [ABSTRACT FROM PUBLISHER]

Subjects :: *COLON cancer
*CANCER treatment
*DRUG side effects
*ADVERSE health care events
*CANCER-related mortality
*CLINICAL trials

Full Text Access

Tools